The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 475.50
Bid: 473.00
Ask: 478.00
Change: 0.00 (0.00%)
Spread: 5.00 (1.057%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 475.50
OCI Live PriceLast checked at -
Oakley Capital Investments is an Investment Trust

To achieve capital appreciation through investments in a diversified portfolio of private mid-market businesses primarily in Europe.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Q&A on Oakley Capital Investments (OCI): 2022 Results: EBITDA Growth Drives NAV Appreciation

31 Mar 2023 08:00

Hardman & Co Research Hardman & Co Q&A on Oakley Capital Investments (OCI): 2022 Results: EBITDA Growth Drives NAV Appreciation 31-March-2023 / 08:00 GMT/BST The issuer is solely responsible for the content of this announcement.


 

Analyst interview |  Investment Companies

Q&A Oakley Capital Investments (OCI) | 2022 Results: EBITDA Growth Drives NAV Appreciation 

Oakley Capital Investments is the topic of conversation when Mark Thomas joins DirectorsTalk Interviews.

Mark gives us an overview of his report entitled ‘2022: NAV returns driven by EBITDA growth’, explains how the investee companies delivered 22% EBITDA growth in challenging markets, what gives Mark confidence in the NAV, how the underlying portfolio companies will cope with recession and any risks involved.

Oakley Capital Investments offers liquid access to a portfolio of high-quality private companies that generate market-leading returns.

 Click on the video image below to listen to the interview..

Dear customer, if you don't see the video, click here 

If you are interested in meeting the company, you can register your interest here

To contact us:

Hardman & Co1 Frederick's Place

London

EC2R 8AE

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Analyst:

Mark Thomas

+44 (0)203 693 7075

 

mt@hardmanandco.com 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259. Attention is drawn to the important disclaimers at the end of the report.


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1597501 31-March-2023 

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
24th Apr 20247:00 amRNSTrading Update for the 3 months ended 31 March 24
2nd Apr 20244:17 pmRNSUpdate from QuotedData
27th Mar 20247:00 amRNSDirector Dealing
27th Mar 20247:00 amRNSDirector Dealing
26th Mar 20245:46 pmRNSHolding(s) in Company
26th Mar 20245:32 pmRNSHolding(s) in Company
18th Mar 20247:00 amRNSOakley Capital invests in Horizons Optical
15th Mar 20244:00 pmRNSQuotedData's Weekly News & Interview
14th Mar 20245:32 pmRNSDividend Declaration
14th Mar 20247:00 amRNSAnnual Results 2023
4th Mar 20247:00 amRNSNotice of Results and Investor Presentation
15th Feb 20247:00 amRNSAppointment of Financial Adviser
13th Feb 20247:00 amRNSDirector Dealing
13th Feb 20247:00 amRNSDirector Dealing
24th Jan 20247:00 amRNSTrading Statement
16th Jan 20247:00 amRNSOakley agrees investment in Steer Automotive Group
15th Jan 20247:00 amRNSHolding(s) in Company
29th Dec 20237:00 amRNSSettlement of Fund I Loan
20th Dec 20239:39 amRNSUpdate from QuotedData
20th Dec 20237:00 amRNSHolding(s) in Company
28th Nov 20232:39 pmRNSResult of AGM
21st Nov 20237:00 amRNSDirector Dealing
7th Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
30th Oct 20237:00 amRNSNotice of AGM and Directorate Change
30th Oct 20237:00 amRNSInvestment in Alerce
26th Oct 202311:14 amRNSInvestment in Webcentral
25th Oct 20237:00 amRNSTrading update for the 3 months ended 30 Sep 2023
18th Oct 20237:00 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSHolding(s) in Company
14th Sep 20235:53 pmRNSInterim Results 2023 - Replacement
14th Sep 20237:00 amRNSInterim Results for the 6 months ended 30 June 23
30th Aug 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSOakley invests in three dental labs businesses
31st Jul 202312:14 pmRNSDirector Dealing
28th Jul 20232:27 pmRNSDirector Dealing
26th Jul 20237:00 amRNSTrading update for the 6 months ended 30 June 2023
26th Jun 20237:00 amRNSDirector Dealing
26th Jun 20237:00 amRNSDirector Dealing
19th Jun 202311:44 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
17th May 20238:04 amRNSOakley Capital extends IU Group partnership
10th May 20237:00 amRNSSale and Reinvestment in IU Group
26th Apr 20237:00 amRNSTrading update for the 3 months ended 31 Mar 2023
18th Apr 20237:00 amRNSOakley partners with schools group Thomas's
4th Apr 20231:13 pmRNSInitiation from QuotedData
31st Mar 20238:00 amEQSHardman & Co Q&A on Oakley Capital Investments (OCI): 2022 Results: EBITDA Growth Drives NAV Appreciation
16th Mar 20237:00 amRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.